NCT01580605已完成不适用
Prospective, Longitudinal and National Follow-up Program of Adult Patients With Somatotropic Hormone Deficiency for Whom Substituting Treatment by Norditropin SimpleXx Was Started
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 331
- 试验地点
- 1
- 主要终点
- Weight
研究概览
简要总结
This study is conducted in Europe. The aim of this study is to extract data from the French National Registry holding information about patients having initiated growth hormone therapy with the objective to describe patients receiving growth hormone therapy, assess efficacy and safety of somatropin (Norditropin® SimpleXx®) and evaluate treatment compliance.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult with growth hormone deficiency
- •Treated with Norditropin® SimpleXx (somatropin)
排除标准
- 未提供
研究组 & 干预措施
Users of somatropin
干预措施: somatropin (Drug)
结局指标
主要结局
Weight
时间窗: Once a year for 5 years
Waist:Hip Ratio
时间窗: Once a year for 5 years
Body composition
时间窗: Once a year for 5 years
Body mass index (BMI)
时间窗: Once a year for 5 years
次要结局
- Lipids: Total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and triglycerides(Once a year for 5 years)
- Dose prescribed(Once a year for 5 years)
- IGF-1 (Insulin-like growth factor 1) concentration(Once a year for 5 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
French National Registry of Children Born Small for Gestational Age Treated With SomatropinGrowth DisorderSmall for Gestational AgeNCT01578135Novo Nordisk A/S291
已完成
不适用
An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®Growth Hormone DisorderAdult Growth Hormone DeficiencyNCT00934063Novo Nordisk A/S121
进行中（未招募）
不适用
Nationwide Observation Study to Evaluate the Efficacy and Tolerance of the Adjustable Medical Device REMEEX® in the Treatment of Male Stress Urinary IncontinenceUrinary Incontinence,StressNCT03650244Centre Hospitalier Universitaire de Nīmes100
已完成
不适用
Observational Study on Levemir® in Obese Diabetic PatientsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT00849342Novo Nordisk A/S580
已完成
不适用
Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASVCentral Sleep Apnea Syndrome in Patients Whose EF is Above 45 PercentCentral Sleep ApneaHeart Failure With Preserved Ejection FractionNCT02835638Société Française de Recherche et de Médecine du Sommeil520